TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post April 1, 1994